The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization

Abstract

The addition of ranolazine to standard anti-ischemic therapy showed a significant improvement in EET results after one month of therapy, including reduced exercise angina, increased exercise tolerance, and reduced exercise arrhythmias.